PredxBio

PredxBio, Inc. is dedicated to developing explainable AI-driven spatial analytics software platforms to unravel the intricate complexities of cancer biology.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded September 2018
  • Employees 9
  • Incorporation Type C-corp
  • Website predxbio.com

Company Summary

PredxBio is a techbio company, headquartered in Pittsburgh, harnessing the power of spatial biology, multimodal data, and explainable AI to unravel the hidden circuitries of cancer. We are making a difference today in predicting patient response to immunotherapy with over 90% accuracy. Our ground-breaking platform aims to transform cancer care with next generation analytics and AI, and accelerate drug development and clinical trials.

Team

  • Chief of AI, COO, & Co-founder

    Outside of his role as the cofounder, president and COO of PredxBio, Chakra was a tenured associate professor at the U. of Pittsburgh, where he initiated the research that provided the basis for the Company’s products. He also has corporate experience at the NEC Research Institute and IBM Almaden Research Center. Prior to Majumdar joining the team, Chakra was the CEO for the company.

  • Prior to joining PredxBio in 2022, Dusty’s experience includes leading strategy and marketing as the CMO at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M over the last three decades. In his tenure at IBM, Dusty oversaw the marketing, commercialization, brand strategy execution and digital initiatives across Healthcare and Life Sciences.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free